Therapy News and Research

RSS
Multi-purpose protein may offer clues for successful treatment of Alzheimer's disease

Multi-purpose protein may offer clues for successful treatment of Alzheimer's disease

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

REVERSE II trial validates HERDOO2 rule to help spot women who can discontinue anticoagulants

Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy

Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy

New anticoagulant treatment safe and effective for AF patients before cardioversion

New anticoagulant treatment safe and effective for AF patients before cardioversion

MedUni Vienna scientists aim to identify prognostic markers for cutaneous lymphomas

MedUni Vienna scientists aim to identify prognostic markers for cutaneous lymphomas

New study suggests major change in treatment of significant number of ACS patients

New study suggests major change in treatment of significant number of ACS patients

Penn scientists find striking similarities between human patients with LCA and dogs

Penn scientists find striking similarities between human patients with LCA and dogs

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Could a light-listening photonics device detect skin disease? An interview with Prof. Vasilis Ntziachristos

Could a light-listening photonics device detect skin disease? An interview with Prof. Vasilis Ntziachristos

NCATS scientists identify promising compounds effective in inhibiting Zika virus replication

NCATS scientists identify promising compounds effective in inhibiting Zika virus replication

Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Researcher receives NIH grant to detect increasing Mtb activity in people with HIV

Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model

Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model

Adults with moderate to severe TBI may be at greater risk of death from unintentional injuries

Adults with moderate to severe TBI may be at greater risk of death from unintentional injuries

Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Fluid-filled sacs that brain cells make to trap amyloid may contribute to Alzheimer's disease

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Lipoprotein apheresis may have new role in patients with refractory angina

Lipoprotein apheresis may have new role in patients with refractory angina

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

Remote monitoring shows no improvement in outcomes for heart failure patients with CIEDs

Remote monitoring shows no improvement in outcomes for heart failure patients with CIEDs

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

HIJ-PROPER trial: Intensive cholesterol-lowering regimen in ACS patients shows no better outcomes

Less invasive infusion strategy not linked to cardiac functional improvements but enhances health status

Less invasive infusion strategy not linked to cardiac functional improvements but enhances health status

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.